Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine and Propranolol in Chronic Low Back Pain
NCT03364075Phase 2Terminated
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of duloxetine and propranolol in chronic low back pain (CLBP) (6 arms). Primary endpoint: Pain Index at 14 days. Started Sep 2017; status: terminated.
02
Drugs
duloxetinepropranolol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT03364075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364075.